| Dec'19 | Dec'18 | Dec'17 | Dec'16 | |||
|---|---|---|---|---|---|---|
Grant revenues | ||||||
1,193 | 2,428 | 2,045 | 589 | |||
Operating expenses: | ||||||
Research and development | ||||||
41,506 | 24,479 | 9,233 | 5,100 | |||
General and administrative | ||||||
13,519 | 6,659 | 1,939 | 1,533 | |||
Total operating expenses | ||||||
55,025 | 31,138 | 11,172 | 6,633 | |||
Loss from operations | ||||||
-53,832 | -28,710 | -9,127 | -6,044 | |||
Other income (expense): | ||||||
Interest income | ||||||
3,460 | 1,748 | 26 | 37 | |||
Interest expense | ||||||
- | - | - | 11 | |||
Other income (expense), net | ||||||
50 | 153 | 56 | 1 | |||
Total other income (expense), net | ||||||
3,410 | 1,595 | -30 | 25 | |||
Net loss | ||||||
-50,422 | -27,115 | -9,157 | -6,019 | |||
Other comprehensive income: | ||||||
Unrealized gain on investment securities | ||||||
87 | 61 | - | - | |||
Comprehensive loss | ||||||
-50,335 | -27,054 | -9,157 | -6,019 | |||
Net loss per share: | ||||||
Net loss per share – basic and diluted | ||||||
-2.09 | -2.23 | -6.68 | -5.96 | |||
Weighted average shares outstanding – basic and diluted | ||||||
24,175 | 12,142 | 1,371 | 1,011 | |||